Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
How do you determine whether to switch to a different anti-VEGF agent or to Ozurdex after a patient with diabetic macular edema fails a series of Avastin?
Related Questions
What is your surgical approach for optic disc pit retinal detachments if laser treatment is unsuccessful?
What’s your approach to managing postoperative inflammation and CME in high-risk patients after cataract surgery?
How do you decide which secondary IOL to place in an aphakic eye?
What is your preferred method for choroidal drainage?
What has been your experience with controlling diabetic macular edema after switching to Eylea HD, especially when restricted to a q8w interval following the loading phase?
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
What factors guide the decision to treat with ROP laser treatment versus a repeat anti-VEGF injection in a child who has previously received anti-VEGF therapy for retinopathy of prematurity (ROP)?
What factors should be considered when deciding the best timing for choroidal drainage in a monocular patient with a suprachoroidal hemorrhage and a concurrent retinal detachment?
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
When should surgical resection be considered for vasoproliferative tumors?
